Intralesional Infusion of Methotrexate as Neoadjuvant Therapy Improves the Cosmetic and Functional Results of Surgery to Treat Keratoacanthoma: Results of a Randomized Trial

Statistics

Original article

Ensayo clínico: la infiltración intralesional con metotrexato de forma neoadyuvante en la cirugía del queratoacantoma permite obtener mejores resultados estéticos y funcionales

A. Martorell-Calatayuda,

Corresponding author

antmarto@hotmail.com

Corresponding author.

, C. Requenaa, E. Nagorea, O. Sanmartína, C. Serra-Guilléna, R. Botella-Estradad, V. Sanz-Motilvab, B. Llombarta, A. Alcañiz-Moscardoc, C. Guillén-Baronaa

a Departamento de Dermatología, Instituto Valenciano de Oncología, Valencia, Spain

b Departamento de Dermatología, Hospital 12 de Octubre, Madrid, Spain

c Departamento de Enfermería, Instituto Valenciano de Oncología, Valencia, Spain

d Servicio de Dermatología, Hospital Universitario la Fe, Valencia, Spain

Read

10601

Times
was read the article

2665

Total PDF

7936

Total HTML

Share statistics

Article information

ISSN: 15782190
Original language: English

DOI:10.1016/j.adengl.2011.03.012

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 April	70	20	90
2024 March	111	43	154
2024 February	116	29	145
2024 January	75	30	105
2023 December	81	22	103
2023 November	107	31	138
2023 October	85	34	119
2023 September	87	30	117
2023 August	78	27	105
2023 July	100	47	147
2023 June	59	25	84
2023 May	73	34	107
2023 April	67	51	118
2023 March	68	48	116
2023 February	81	39	120
2023 January	46	47	93
2022 December	68	55	123
2022 November	53	32	85
2022 October	39	27	66
2022 September	47	46	93
2022 August	56	49	105
2022 July	33	53	86
2022 June	30	37	67
2022 May	35	51	86
2022 April	59	71	130
2022 March	45	73	118
2022 February	44	40	84
2022 January	46	74	120
2021 December	38	66	104
2021 November	53	46	99
2021 October	92	73	165
2021 September	38	46	84
2021 August	46	30	76
2021 July	45	38	83
2021 June	49	34	83
2021 May	45	41	86
2021 April	114	39	153
2021 March	72	26	98
2021 February	65	21	86
2021 January	33	16	49
2020 December	46	27	73
2020 November	36	20	56
2020 October	29	13	42
2020 September	43	15	58
2020 August	30	15	45
2020 July	34	13	47
2020 June	32	35	67
2020 May	42	21	63
2020 April	50	28	78
2020 March	46	27	73
2020 February	5	12	17
2020 January	0	14	14
2019 December	6	8	14
2019 November	0	5	5
2019 October	0	4	4
2019 September	7	7	14
2019 August	0	15	15
2019 July	0	17	17
2019 June	0	13	13
2019 May	5	28	33
2019 April	1	35	36
2019 March	0	12	12
2019 February	2	8	10
2019 January	2	0	2
2018 November	2	0	2
2018 October	3	0	3
2018 March	5	0	5
2018 February	63	4	67
2018 January	87	8	95
2017 December	92	10	102
2017 November	85	5	90
2017 October	62	3	65
2017 September	80	4	84
2017 August	111	12	123
2017 July	90	7	97
2017 June	113	14	127
2017 May	79	5	84
2017 April	76	9	85
2017 March	56	3	59
2017 February	70	11	81
2017 January	123	13	136
2016 December	105	10	115
2016 November	174	7	181
2016 October	123	12	135
2016 September	257	4	261
2016 August	136	8	144
2016 July	74	7	81
2016 June	13	5	18
2016 May	12	14	26
2016 April	1	15	16
2016 March	7	7	14
2016 February	6	9	15
2016 January	6	1	7
2015 December	7	1	8
2015 November	14	1	15
2015 October	11	10	21
2015 September	5	0	5
2015 August	18	1	19
2015 July	176	6	182
2015 June	134	10	144
2015 May	135	17	152
2015 April	143	20	163
2015 March	158	9	167
2015 February	142	9	151
2015 January	110	8	118
2014 December	109	7	116
2014 November	82	10	92
2014 October	102	17	119
2014 September	107	12	119
2014 August	69	11	80
2014 July	87	17	104
2014 June	105	16	121
2014 May	115	23	138
2014 April	111	11	122
2014 March	125	23	148
2014 February	97	16	113
2014 January	122	16	138
2013 December	113	13	126
2013 November	102	10	112
2013 October	75	22	97
2013 September	33	10	43
2013 August	30	16	46
2013 July	17	18	35
2013 June	15	17	32
2013 May	13	10	23
2013 April	8	8	16
2013 March	19	7	26
2013 February	32	7	39
2013 January	76	6	82
2012 December	40	4	44
2012 November	2	4	6
2012 October	1	2	3

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter